Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative anticoagulation strategies in spinal metastatic tumor surgery
ChiCTR2100042058Phase 4Recruiting
- Sponsor
- Department of Orthopedic Oncology, Changzheng Hospital
- Start
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of low molecular weight heparin calcium in spinal neoplasm and venous thromboembolism (VTE) (4 arms), sponsored by Department of Orthopedic Oncology, Changzheng Hospital. Primary endpoints: Thrombotic event, Bleeding event and 3 more. Started Jan 2021; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
spinal neoplasmvenous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR2100042058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042058.